Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis.
暂无分享,去创建一个
[1] P. O S I T I O N S T A T E M E N T. Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.
[2] V. Basevi. Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.
[3] Michele Tarsilla. Cochrane Handbook for Systematic Reviews of Interventions , 2010, Journal of MultiDisciplinary Evaluation.
[4] R. Norman,et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. , 2010, Human reproduction.
[5] P. O S I T I O N S T A T E M E N T,et al. Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.
[6] G. Watts,et al. Dissociation of endothelial function and arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS) , 2009, Clinical endocrinology.
[7] F. Vaisman,et al. Central-to-peripheral fat ratio, but not peripheral body fat, is related to insulin resistance and androgen markers in polycystic ovary syndrome , 2009, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[8] G. Zoppini,et al. Body fat and insulin resistance independently predict increased serum C-reactive protein in hyperandrogenic women with polycystic ovary syndrome. , 2009, European journal of endocrinology.
[9] L. Moran,et al. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome. , 2009, Human reproduction update.
[10] S. Bhattacharya. Polycystic ovary syndrome and abnormalities in glucose tolerance , 2009, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[11] J. Shaw,et al. The metabolic syndrome: in need of a global mission statement , 2009, Diabetic medicine : a journal of the British Diabetic Association.
[12] A. Moini,et al. Familial associations between polycystic ovarian syndrome and common diseases , 2009, Journal of Assisted Reproduction and Genetics.
[13] R. Corcoy,et al. Prevalence and predictors of abnormal glucose metabolism in Mediterranean women with polycystic ovary syndrome , 2009, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[14] M. Eijkemans,et al. Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria. , 2008, Human reproduction.
[15] L. Salazar,et al. Association between CAPN10 UCSNP-43 gene polymorphism and polycystic ovary syndrome in Chilean women. , 2008, Clinica chimica acta; international journal of clinical chemistry.
[16] M. Maliqueo,et al. Polymorphism T --> C (-34 base pairs) of gene CYP17 promoter in women with polycystic ovary syndrome is associated with increased body weight and insulin resistance: a preliminary study. , 2008, Metabolism: clinical and experimental.
[17] J. Shaw,et al. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome. , 2008, Human reproduction.
[18] C. Stehouwer,et al. Obese but not normal-weight women with polycystic ovary syndrome are characterized by metabolic and microvascular insulin resistance. , 2008, The Journal of clinical endocrinology and metabolism.
[19] F. Grigorescu,et al. FTO gene associates to metabolic syndrome in women with polycystic ovary syndrome. , 2008, Biochemical and biophysical research communications.
[20] T. Welborn,et al. The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study , 2008, Journal of Internal Medicine.
[21] W. So,et al. Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome. , 2008, Human reproduction.
[22] S. Reis,et al. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. , 2008, The Journal of clinical endocrinology and metabolism.
[23] M. McCarthy,et al. Global adiposity rather than abnormal regional fat distribution characterizes women with polycystic ovary syndrome. , 2008, The Journal of clinical endocrinology and metabolism.
[24] J. Shaw,et al. Glucose Indices, Health Behaviors, and Incidence of Diabetes in Australia , 2007, Diabetes Care.
[25] S. Bhattacharya. Metabolic syndrome in females with polycystic ovary syndrome and International Diabetes Federation criteria , 2007, The journal of obstetrics and gynaecology research.
[26] R. Serter,et al. Association of hypoadiponectinemia with metabolic syndrome in patients with polycystic ovary syndrome. , 2008, Journal of the National Medical Association.
[27] E. Carmina,et al. Differences in dyslipidemia between American and Italian women with polycystic ovary syndrome , 2008, Journal of endocrinological investigation.
[28] R. Azziz,et al. Impact of obesity on the risk for polycystic ovary syndrome. , 2008, The Journal of clinical endocrinology and metabolism.
[29] E. V. van Beek,et al. Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis. , 2007, The Journal of clinical endocrinology and metabolism.
[30] E. Wickham,et al. Glucose intolerance in polycystic ovary syndrome--a position statement of the Androgen Excess Society. , 2007, The Journal of clinical endocrinology and metabolism.
[31] William A. Davis,et al. Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria. , 2007, Fertility and sterility.
[32] J. Baillargeon,et al. Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity. , 2007, Fertility and sterility.
[33] J. Shaw,et al. The metabolic syndrome in Australia: prevalence using four definitions. , 2007, Diabetes research and clinical practice.
[34] H. Escobar-Morreale,et al. Abdominal adiposity and the polycystic ovary syndrome , 2007, Trends in Endocrinology & Metabolism.
[35] S. Zoungas,et al. The management of insulin resistance in polycystic ovary syndrome , 2007, Trends in Endocrinology & Metabolism.
[36] P Zimmet,et al. International Diabetes Federation: a consensus on Type 2 diabetes prevention , 2007, Diabetic medicine : a journal of the British Diabetic Association.
[37] Judith R. Rager,et al. Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women. , 2007, Journal of women's health.
[38] T. Kılıç,et al. The Frequency of Metabolic Syndrome in Women with Polycystic Ovaries at Reproductive Age and Comparison of Different Diagnostic Criteria for Metabolic Syndrome , 2007 .
[39] J. Adams,et al. Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features. , 2006, The Journal of clinical endocrinology and metabolism.
[40] M. Eijkemans,et al. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. , 2006, Human reproduction update.
[41] M. Himelein,et al. Polycystic Ovary Syndrome and Mental Health: A Review , 2006, Obstetrical & gynecological survey.
[42] R. Norman,et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. , 2006, The Journal of clinical endocrinology and metabolism.
[43] J. L. San Millán,et al. Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women. , 2006, Archives of internal medicine.
[44] J. Selbig,et al. Predicting impaired glucose metabolism in women with polycystic ovary syndrome by decision tree modelling , 2006, Diabetologia.
[45] A. Papavassiliou,et al. Molecular mechanisms of insulin resistance in polycystic ovary syndrome. , 2006, Trends in molecular medicine.
[46] E. Schisterman,et al. Selecting controls is not selecting "normals": design and analysis issues for studying the etiology of polycystic ovary syndrome. , 2006, Fertility and sterility.
[47] M. Kocherginsky,et al. Relationship of adolescent polycystic ovary syndrome to parental metabolic syndrome. , 2006, The Journal of clinical endocrinology and metabolism.
[48] A. Go,et al. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. , 2006, The Journal of clinical endocrinology and metabolism.
[49] E. Talbott,et al. Risk of T2DM and impaired fasting glucose among pcos subjects: Results of an 8-year follow-up , 2006, Current diabetes reports.
[50] R. Legro,et al. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. , 2006, The Journal of clinical endocrinology and metabolism.
[51] R. Krauss,et al. Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement , 2005, Current opinion in cardiology.
[52] N. Napoli,et al. Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS. , 2006, European journal of endocrinology.
[53] D. Ehrmann,et al. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. , 2006, The Journal of clinical endocrinology and metabolism.
[54] D. Cibula,et al. Metabolic syndrome in young Czech women with polycystic ovary syndrome. , 2005, Human reproduction.
[55] J. Santiprabhob,et al. Obese adolescent girls with polycystic ovary syndrome (PCOS) have more severe insulin resistance measured by HOMA-IR score than obese girls without PCOS. , 2005, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[56] Ralph B D'Agostino,et al. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. , 2005, Diabetes.
[57] Fernando Costa,et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. , 2005, Circulation.
[58] C. Glueck,et al. Obesity and extreme obesity, manifest by ages 20-24 years, continuing through 32-41 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathy. , 2005, European journal of obstetrics, gynecology, and reproductive biology.
[59] H. Teede,et al. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease. , 2005, The Journal of clinical endocrinology and metabolism.
[60] Paul Zimmet,et al. The metabolic syndrome—a new worldwide definition , 2005, The Lancet.
[61] J. Cameron,et al. Vascular dysfunction and metabolic parameters in polycystic ovary syndrome. , 2005, The Journal of clinical endocrinology and metabolism.
[62] R. Azziz,et al. Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. , 2005, The Journal of clinical endocrinology and metabolism.
[63] A. Dokras,et al. Screening Women With Polycystic Ovary Syndrome for Metabolic Syndrome , 2005, Obstetrics and gynecology.
[64] A. Kunselman,et al. Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study. , 2005, The Journal of clinical endocrinology and metabolism.
[65] J. Nestler,et al. 0021-972X/05/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 90(4):1929–1935 Printed in U.S.A. Copyright © 2005 by The Endocrine Society doi: 10.1210/jc.2004-1045 Prevalence and Characteristics of the Metabolic Syndrome in Women with Polycysti , 2022 .
[66] E. Diamanti-Kandarakis,et al. Increased levels of serum advanced glycation end‐products in women with polycystic ovary syndrome , 2005, Clinical endocrinology.
[67] R. Krauss,et al. Diagnosis and management of the metabolic syndrome , 2005 .
[68] C. Duman,et al. Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation. , 2004, The Journal of clinical endocrinology and metabolism.
[69] Judith R. Rager,et al. Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome. , 2004, The Journal of clinical endocrinology and metabolism.
[70] K. Gauvreau,et al. Prevalence of the Metabolic Syndrome in American Adolescents: Findings From the Third National Health and Nutrition Examination Survey , 2004, Circulation.
[71] J. Santos,et al. Insulin secretion in women who have polycystic ovary syndrome and carry the Gly972Arg variant of insulin receptor substrate-1 in response to a high-glycemic or low-glycemic carbohydrate load. , 2004, Nutrition.
[72] F. Orio,et al. Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome. , 2004, The Journal of clinical endocrinology and metabolism.
[73] U. Pagotto,et al. Glucose intolerance in a large cohort of mediterranean women with polycystic ovary syndrome: phenotype and associated factors. , 2004, Diabetes.
[74] T. Lesnick,et al. Insulin and messenger ribonucleic acid expression of insulin receptor isoforms in ovarian follicles from nonhirsute ovulatory women and polycystic ovary syndrome patients. , 2004, The Journal of clinical endocrinology and metabolism.
[75] D. Cibula,et al. Insulin sensitivity in women with polycystic ovary syndrome. , 2004, The Journal of clinical endocrinology and metabolism.
[76] M. Boscaro,et al. Body composition, fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome , 2004, Journal of endocrinological investigation.
[77] P. Claman. Men at risk: occupation and male infertility. , 2004, Fertility and sterility.
[78] R. Legro,et al. Detecting Insulin Resistance in Polycystic Ovary Syndrome: Purposes and Pitfalls , 2004, Obstetrical & gynecological survey.
[79] Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. , 2004, Fertility and sterility.
[80] B. Fauser,et al. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.
[81] S. Haffner,et al. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. , 2003, Diabetes care.
[82] R. Bergman,et al. Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors? , 2003, Diabetes care.
[83] W. Dietz,et al. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. , 2003, Archives of pediatrics & adolescent medicine.
[84] N. Goldenberg,et al. Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. , 2003, Metabolism: clinical and experimental.
[85] E. Guney,et al. Platelet dysfunction in lean women with polycystic ovary syndrome and association with insulin sensitivity. , 2003, The Journal of clinical endocrinology and metabolism.
[86] R. Cífková,et al. Cardiovascular risk factors in young Czech females with polycystic ovary syndrome. , 2003, Human reproduction.
[87] P. Raskin,et al. Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.
[88] J. Mckenney,et al. National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .
[89] G. Reaven. Metabolic Syndrome: Pathophysiology and Implications for Management of Cardiovascular Disease , 2002, Circulation.
[90] M. Hill,et al. Insulin sensitivity and beta-cell function in women with polycystic ovary syndrome. , 2002, Diabetes care.
[91] S. Emans,et al. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. , 2002, The Journal of clinical endocrinology and metabolism.
[92] M. Hill,et al. Insulin sensitivity and beta-cell function in women with polycystic ovary syndrome. , 2002, Diabetes care.
[93] A. Kunselman,et al. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. , 2001, The American journal of medicine.
[94] A. Oto,et al. Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome. , 2001, Fertility and sterility.
[95] M. Davies,et al. Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome. , 2001, Human reproduction.
[96] E. Diamanti-Kandarakis,et al. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). , 2001, American journal of physiology. Endocrinology and metabolism.
[97] I. Vauhkonen,et al. Metabolic and steroidogenic alterations related to increased frequency of polycystic ovaries in women with a history of gestational diabetes. , 2001, The Journal of clinical endocrinology and metabolism.
[98] L. Groop,et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. , 2001, Diabetes care.
[99] P. McKeigue,et al. Cardiovascular disease in women with polycystic ovary syndrome at long‐term follow‐up: a retrospective cohort study , 2000, Clinical endocrinology.
[100] R. Cífková,et al. Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome. , 2000, Human reproduction.
[101] M. Laakso,et al. Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with Type II diabetes , 2000, Diabetologia.
[102] E. Diamanti-Kandarakis,et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. , 1999, The Journal of clinical endocrinology and metabolism.
[103] W. Dodson,et al. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. , 1999, The Journal of clinical endocrinology and metabolism.
[104] M. Cavaghan,et al. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. , 1999, Diabetes care.
[105] P. Zimmet,et al. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.
[106] S. Wild,et al. Mortality of women with polycystic ovary syndrome at long-term follow-up. , 1998, Journal of clinical epidemiology.
[107] A. Lanzone,et al. Acute insulin response to intravenous glucagon in polycystic ovary syndrome. , 1998, Human reproduction.
[108] L. Bouter,et al. Insulin and risk of cardiovascular disease: a meta-analysis. , 1998, Circulation.
[109] J. Widimský,et al. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus , 1998, Diabetes Care.
[110] A. Lanzone,et al. Heterogeneity in beta cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome. , 1997, Human reproduction.
[111] A. Folsom,et al. A Prospective Study of Coronary Heart Disease in Relation to Fasting Insulin, Glucose, and Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study , 1997, Diabetes Care.
[112] D. Finegood,et al. Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. , 1996, The Journal of clinical endocrinology and metabolism.
[113] R. Clayton,et al. Polymorphism of glycogen synthetase gene in polycystic ovary syndrome , 1996, Clinical endocrinology.
[114] C. Berne,et al. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. , 1995, The Journal of clinical endocrinology and metabolism.
[115] G. Kaltsas,et al. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. , 1995, Human reproduction.
[116] M. Byrne,et al. Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. , 1995, The Journal of clinical investigation.
[117] M. Foss,et al. Insulin secretion in obese and non-obese women with polycystic ovary syndrome and its relationship with hyperandrogenism. , 1995, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[118] R. Norman,et al. Ethnic differences in insulin and glucose response to glucose between white and Indian women with polycystic ovary syndrome. , 1995, Fertility and sterility.
[119] E. Ravussin,et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. , 1993, The New England journal of medicine.
[120] K. Polonsky,et al. Defects in beta-cell function in functional ovarian hyperandrogenism. , 1993, The Journal of clinical endocrinology and metabolism.
[121] C. Bengtsson,et al. Fasting Serum Insulin Concentration and Early Insulin Response as Risk Determinants for Developing Diabetes , 1990, Diabetic medicine : a journal of the British Diabetic Association.
[122] S. Haffner,et al. Incidence of Type II Diabetes in Mexican Americans Predicted by Fasting Insulin and Glucose Levels, Obesity, and Body-Fat Distribution , 1990, Diabetes.
[123] H. Mason,et al. DIFFERENCES IN CLINICAL AND ENDOCRINE FEATURES BETWEEN OBESE AND NON‐OBESE SUBJECTS WITH POLYCYSTIC OVARY SYNDROME: AN ANALYSIS OF 263 CONSECUTIVE CASES , 1990, Clinical endocrinology.
[124] K. Segal,et al. Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome , 1989, Diabetes.
[125] G. Okoev,et al. [Diagnostic criteria for polycystic ovary syndrome]. , 1989, Akusherstvo i ginekologiia.
[126] Robert E. Jones,et al. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. , 1988, The Journal of clinical endocrinology and metabolism.
[127] R. Barbieri,et al. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. , 1986, The Journal of clinical endocrinology and metabolism.
[128] Diabetes mellitus. Report of a WHO Study Group. , 1985, World Health Organization technical report series.
[129] WHO Expert Committee on Diabetes Mellitus: second report. , 1980, World Health Organization technical report series.
[130] Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance , 1979, Diabetes.
[131] M. Goklany. Report of Study Group I , 1973 .